Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
Location:Home > Pharma China Web Edition > Other News    
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Expert Opinions
Case Studies
Company Profiles
Editor´s Picks
WiCON International Group
311 Sayre Drive,
Princeton, NJ 08540, USA
Tel/Fax: +1 702-9953905

China Head Office
c/o Beijing Jicai PharmTech
Suite B-17D, Oriental Kenzo Plaza
48 Dongzhimenwai Dajie
Dongcheng District
Beijing 100027, China
Tel: +86 10 84476010
Fax: +86 10 84476010
Other News
Upcoming Event: Biologics Manufacturing Asia 2020

Event: Biologics Manufacturing Asia 2020
: February 18 19, 2020
Venue: Suntec Convention Centre Singapore, Singapore
Weblink: www.imapac.com/en/business_conferences/biologics-manufacturing-asia/?popup#agenda
Contact: Ms. Aisyah Atiqah
Tel: +65 3109 0158
Email: aisyah.atiqah@imapac.com

The biologics industry in Asia- Pacific is estimated to be the fastest growing market in the world. For instance, Asia- Pacific accounts for 30-40% of the global biosimilars market. The key drivers driving the growth of the biologics industry in Asia are competitive manufacturing costs, the increase in of high-skilled workers, new- cell culture techniques, fast-track flexible GMP facilities equipped with disposables, attempts for integrated continuous manufacturing, combining modular facilities, single-use and other advances in the downstream processing of biologics. However, the factors hindering the growth of the biopharmaceutical industry mainly are from the bioprocessing side including high-manufacturing complexities, expensive purification processes and other challenges across the bioprocessing value chain.

To facilitate brainstorming, strategy-generating discussions on the aforementioned key aspects of the biologics industry, IMAPAC is bringing to you 2 focus areas:

Bio-Manufacturing and Cell Therapy Manufacturing and Supply Chain as part of Asia's biggest, most focussed annual bioprocessing conference, the 7th Annual Biologics Manufacturing Asia 2020!

In 2020, 500+ bio manufacturing stakeholders from BIG Pharma, Biopharma, Contract Manufacturing Organisations, Academic & Research Institutes, Regulatory Authorities, and Solution Providers across Singapore, South Korea, Taiwan, Japan, Australia, India, South East Asia, Indo China, and China will convene to discover, discuss and debate on the best manufacturing practices to make better biologic drugs cheaper and faster! 

The convention aims to provide a neutral platform to address the challenges faced in this sector including:

  • Understanding and evaluating in-line process analytical testing approaches for process controls and automation for semi-continuous manufacturing, reduced waste and downtime with increased profitability.
  • The necessity for unit operations to be connected to facilitate a continuous or semi-continuous product flow and consequently need to be controlled simultaneously.
  • The need to take advantage of real-time monitoring data of cell culture behaviour and product characteristics during development for enactment of a robust compliant process control system.
  • Development of robust processes to suit evolving bio manufacturing needs.
  • Optimization of downstream purification for highly complex molecules.
  • Designing and automating quality control during scale-up and process change.
  • Cost-Benefit analysis between the use of disposables vs hard-piped steel containers vs hybrid facilities.Perceived barriers to switch over from batch to continuous manufacturing and the future prospects and challenges faced by companies planning for the paradigm shift.

Join us in 2020 in Singapore: the biomanufacturing hub of Asia, strong government support, easy access from all Asian countries, technological leadership and home to top biopharmaceutical companies developing smart manufacturing facilities for the production of biologic drugs, to convene on the best manufacturing practices in order to have access to faster, cheaper and better biologic drugs!

Relate News  
© Wicon International Group  Support by: www.heightow.com   Site map | Contact Us | Links